Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Using serum troponins to screen for cardiac involvement and assess disease activity in the idiopathic inflammatory myopathies

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

    Research output: Contribution to journalJournal articleResearchpeer-review

  • James B Lilleker
  • Axel C P Diederichsen
  • Søren Jacobsen
  • Mark Guy
  • Mark E Roberts
  • Jamie C Sergeant
  • Robert G Cooper
  • Louise P Diederichsen
  • Hector Chinoy
View graph of relations

Objectives: Limitations in the methods available for identifying cardiac involvement and accurately quantifying disease activity in the idiopathic inflammatory myopathies (IIMs) may contribute to poor outcomes. We investigated the utility of different serum muscle damage markers [total creatine kinase (CK), cardiac troponin T (cTnT) and cardiac troponin I (cTnI)] to address these issues.

Methods: We assessed disease activity and cardiac involvement using the International Myositis Assessment and Clinical Studies Group core set measures in 123 participants with confirmed adult-onset IIM from the UK and Denmark. Total CK, cTnT and cTnI were measured. Associations were assessed using logistic regression and Spearman's ranked correlation.

Results: Cardiac involvement (n = 18) was associated with higher cTnI levels, independent of overall disease activity [adjusted odds ratio 1.03 (95% CI 1.01, 1.05); P = 0.002]. An abnormal cTnI had the highest specificity and positive predictive value for cardiac involvement (95% and 62%, respectively). In those with a normal CK but elevated cTnT or cTnI, an association with increased disease activity scores was observed. Serum cTnT correlated with the physician (ρ = 0.39) and patient-assessed (ρ = 0.28) global visual analogue scales and HAQ (ρ = 0.41) more strongly than CK or cTnI levels. cTnT was the only marker to correlate with manual muscle testing scores (ρ = -0.24).

Conclusion: Serum cTnI testing may have a role in screening for cardiac involvement in IIMs. Abnormal levels of serum cTnT and cTnI are associated with increased disease activity, including in those with a normal CK.

Original languageEnglish
JournalRheumatology (Oxford, England)
Volume57
Issue number6
Pages (from-to)1041-1046
Number of pages6
ISSN1462-0324
DOIs
Publication statusPublished - Jun 2018

    Research areas

  • Biomarkers/blood, Cardiomyopathies/blood, Denmark/epidemiology, Echocardiography, Electrocardiography, Female, Humans, Incidence, Male, Middle Aged, Myositis/blood, Predictive Value of Tests, Prevalence, ROC Curve, Severity of Illness Index, Troponin I/blood, Troponin T/blood, United Kingdom/epidemiology

ID: 55216847